Sonoma Pharmaceuticals Inc Asset Resilience Ratio
Sonoma Pharmaceuticals Inc asset resilience ratio. Sonoma Pharmaceuticals Inc (SNOA) has an Asset Resilience Ratio of 0.00% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SNOA defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sonoma Pharmaceuticals Inc (2007–2018)
Asset resilience ratio of Sonoma Pharmaceuticals Inc from 2007 to 2018. This chart shows how Sonoma Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. Read SNOA total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sonoma Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SNOA current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Sonoma Pharmaceuticals Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Sonoma Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio
Compare Sonoma Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Sonoma Pharmaceuticals Inc Asset Resilience Ratio by Year (2007–2018)
Sonoma Pharmaceuticals Inc asset resilience ratio by year from 2007 to 2018. The table below shows the annual Asset Resilience Ratio data for Sonoma Pharmaceuticals Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-03-31 | 0.00% | $0.00 | $19.21 Million | -- |
| 2017-03-31 | 0.00% | $0.00 | $25.46 Million | -- |
| 2016-03-31 | 0.00% | $0.00 | $13.80 Million | -- |
| 2015-03-31 | 0.00% | $0.00 | $15.05 Million | -- |
| 2014-03-31 | 0.00% | $0.00 | $20.79 Million | -- |
| 2013-03-31 | 0.00% | $0.00 | $12.56 Million | -- |
| 2012-03-31 | 0.00% | $0.00 | $7.84 Million | -- |
| 2007-03-31 | 7.42% | $2.00 Million | $26.95 Million | -- |
About Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin f… Read more